Global University Venturing

Alexandria Venture Investments was among the participants in a series A for the cellular cancer therapeutics developer based on work at Institut Curie and Memorial Sloan Kettering.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Broad Institute and UPenn-linked cardiovascular disease drug developer Verve priced an upscaled initial public offering above its range.

Umoja Biopharma, based on research at Purdue University and Seattle Children’s Research Institute, has picked up a series B co-led by SoftBank Vision Fund 2.

Motif FoodWorks, which traces its roots to MIT, has pocketed $226m in a round backed by returning investor Louis Dreyfus a month after Motif’s parent agreed to a reverse merger.

UCL Technology Fund has participated in a $145m round that will allow Apollo Therapeutics to advance assets into the clinic and open a US office.

Maryland Momentum Fund and VTC Innovation Fund have both contributed to a series A round for Veralox Therapeutics, which is focusing on diseases with unmet needs.

UTokyo IPC has contributed to a funding round for Telexistence that brought the remote-controlled robotics technology developer’s total funding to $41m.

The accelerator will welcome agtech and foodtech developers for a 12-week programme, with Atlantic Bridge among those providing mentoring.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Uniseed has returned for the latest round raised by Melbourne spinout ENA Respiratory, which is working on a nasal spray to prevent covid-19.